comprehensive -WSS

comprehensive

author：fashion 2025-10-01 17:34:24 - browse：61789

Principal Deputy FDA Commissioner Janet Woodcock Stefani Reynolds/The New York Times via AP

WASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the Food and Drug Administration after helping steer the agency through an historic period of medical advances during nearly four decades in key leadership positions, she confirmed to STAT Thursday.

Woodcock, a doctor with a chemistry degree, joined FDA in 1986 at its biologics center, where she oversaw the approval of the first biotechnology-based treatments for multiple sclerosis and cystic fibrosis. In 1994, she was named director of the drug center, where she played a key role in guiding some of the most impactful changes to the regulation of medicine, according to Trump administration FDA Commissioner Scott Gottlieb.

Woodcock envisioned that antibody drugs would become a backbone of therapy and created a more predictable regulatory path for their review and approval, Gottlieb said. She presided over a major expansion and modernization of the generic drug program, standardizing reviews in a way that allowed the industry to become safer and more robust, and crafted the reform of over-the-counter drug reviews.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Biotech incubator Curie.Bio graduates its first startup

WSS

Medicare will require more price transparency from hospitals

New Alzheimer's drugs heat up race for early detection blood tests

The haunting brain science of long Covid

Rise in cancer among younger people worries and puzzles doctors

CDC Director Mandy Cohen on transparency, trust, and health

White House calls on federal agencies to crack down on AI abuses

Wikipedia

comprehensive

knowledge

Malaria cases in Florida and Texas: Here’s what you need to know

A clever new way to fix Medicaid and graduate medical education

Psychedelics group wrestles with new pharma identity

Dems pitch expanding Medicare power to negotiate drug prices

BioMarin wins approval for gene therapy to treat hemophilia A

Rise in cancer among younger people worries and puzzles doctors

George Santos makes 1st court appearance after pleading not guilty to 13 counts

HPV cancer vaccine study demonstrates efficacy

The high cost of giving birth even with insurance

What to watch for from Zogenix and Amicus clinical trials

explore

New lawsuit accuses health insurer Cigna of denying claims in bulk

STAT Report: Patient voices and perspectives

What it's like to live with paralysis for one psychologist

Abortion clinic in Cancun will cater to Americans

Medicare will require more price transparency from hospitals

Excited delirium, Elijah McClain, and emergency physicians

focus

knowledge

entertainment

hotspot